Report Library
All ReportsDatamonitor Healthcare Oncology: Breast Cancer: Triple-Negative Disease Coverage
May 09, 2018
Triple-negative breast cancer is characterized by the absence of estrogen and progesterone receptors, and does not involve overexpression
of
human epidermal growth factor 2 (HER2). It is associated with poor prognosis, a high risk of local recurrence, and poor disease-free and
cancer-specific survival. Overall, breast cancer is the second most common cancer and the second leading cause of cancer-related deaths in
women worldwide. In the US, breast cancer is the third leading cause of cancer-related deaths, regardless of gender, behind lung cancer and
colorectal cancer.
This Datamonitor Healthcare Disease report contains Forecast, Treatment, Epidemiology, Marketed Drugs, and Pipeline modules.
This Datamonitor Healthcare Disease report contains Forecast, Treatment, Epidemiology, Marketed Drugs, and Pipeline modules.
Indications Covered: | Breast Cancer |